Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01038076 · ClinicalTrials.gov registry record · NA

Medications for Chronic HIV: Education and Collaboration

A NA study of HIV Infections and Medication Adherence, sponsored by Boston University.

Completed
Registry status
NA
Development phase
371
Enrollment target
3
Study locations

NCT01038076 is a NA study of HIV Infections and Medication Adherence that has completed, run by Boston University. The registered enrollment target is 371 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (17% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01038076, a NA study of HIV Infections and Medication Adherence, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
371 participants
Enrollment target
3
Study locations

Study Summary

This study will examine whether a computerized, self-administered assessment of patient medication adherence and health behaviors, plus support for adherence, improves the ability of clinicians to identify adherence problems and leads to better adherence.

Interventions

  • BEHAVIORAL MedCHEC Tablet Computer & Adherence Care

Study Locations (3)

Massachusetts

  • VA Boston - Boston
  • Boston Medical Center - Boston

California

  • VA Greater Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 371 participants
Start Date 2009-12
Est. Completion 2017-12
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT01038076

The ClinicalTrials.gov registry entry for NCT01038076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (17% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which MedCHEC Tablet Computer & Adherence Care is the first listed.

NCT01038076 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, California.

Frequently Asked Questions

What is clinical trial NCT01038076 about?

NCT01038076 is a clinical study titled "Medications for Chronic HIV: Education and Collaboration". This study will examine whether a computerized, self-administered assessment of patient medication adherence and health behaviors, plus support for adherence, improves the ability of clinicians to identify adherence problems and leads to better adherence.

What is the current status of trial NCT01038076?

This trial is currently completed. It is a NA study. The enrollment target is 371 participants. The study started on 2009-12. Estimated completion is 2017-12.

What conditions does trial NCT01038076 study?

This clinical trial studies the following conditions: HIV Infections, Medication Adherence, Acquired Immunodeficiency Syndrome.

What interventions are being tested in trial NCT01038076?

The interventions under investigation include: MedCHEC Tablet Computer & Adherence Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01038076?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01038076 being conducted?

This trial has 3 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.